Results from Medicare’s first year of negotiation with other price benchmarks shed light on the competitive dynamics and ...

marking the seventh loss in the legal battle by drugmakers and their allies. Although the drug manufacturers have repeatedly said that price negotiations will hurt their businesses and reduce ...

Currently, health plan sponsors contracted by Medicare to administer coverage of drugs under the program’s Part D benefit negotiate rebates from drugmakers, resulting in non-public net prices.

J&J CEO explained that the new drug-price negotiation law threatens development of new drugs, according to Bloomberg.

Will older adults see the savings at all if drugmakers succeed in having the negotiations blocked by the courts? “Lower ...

Healthcare players are pointing fingers amid regulatory crackdowns on pharmacy benefit managers, but proposed reforms ...

the Centers for Medicare and Medicaid Services have the ability to negotiate directly with pharmaceutical companies for the price of medications — and impose punitive taxes if the drugmakers ...

Medicare and drugmakers have completed negotiations to cut drug prices for 10 of Medicare's most common and most expensive drugs starting in 2026. Some medications help manage diabetes ...

But drugmakers are often able to extend U.S ... Each year, more drugs will be up for price negotiation by Medicare, which accounts for about a third of U.S. drug spending. "We're going to see ...